Company Filing History:
6 out of 159 
6 out of 100 
1 out of 1 Years Active: 2019-2025
Title: Yayuan Fu: Innovator in IL-2 Mutants
Introduction
Yayuan Fu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of IL-2 mutants. With a total of 8 patents to his name, his work has implications for pharmaceutical applications and disease treatment.
Latest Patents
One of Yayuan Fu's latest patents is titled "IL-2 mutant and application thereof." This patent discloses IL-2 mutants and their various uses. Specifically, it provides details on IL-2 mutants, corresponding fusion proteins, conjugates, nucleic acid fragments, vectors, host cells, and methods for preparing these mutants or fusion proteins. The patent also discusses pharmaceutical compositions and methods for treating diseases, particularly focusing on preferentially stimulating regulatory T cells. Compared to wild-type IL-2, the mutants described in this patent exhibit higher Tm values and improved stability. Additionally, they may have increased yield or altered binding activity to the IL-2Rβγ complexes.
Career Highlights
Yayuan Fu has worked with notable companies in the pharmaceutical industry, including Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in the development of innovative biopharmaceutical solutions.
Collaborations
Throughout his career, Yayuan Fu has collaborated with several professionals in the field, including Weikang Tao and Zhuoxiao Cao. These collaborations have likely enhanced his research and development efforts.
Conclusion
Yayuan Fu is a distinguished inventor whose work on IL-2 mutants has the potential to advance therapeutic strategies in medicine. His contributions to biotechnology and collaboration with industry leaders underscore his impact in the field.